Internet Content & Information
Compare Stocks
5 / 10Stock Comparison
NAMI vs AIXI vs BBAI vs CLPS vs CODA
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Information Technology Services
Information Technology Services
Aerospace & Defense
NAMI vs AIXI vs BBAI vs CLPS vs CODA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Internet Content & Information | Software - Application | Information Technology Services | Information Technology Services | Aerospace & Defense |
| Market Cap | $11M | $8M | $19.73B | $25M | $134M |
| Revenue (TTM) | $406M | $115M | $127M | $299M | $28M |
| Net Income (TTM) | $20M | $-53M | $-289M | $-4M | $4M |
| Gross Margin | 28.8% | 64.3% | 25.8% | 22.8% | 66.3% |
| Operating Margin | 6.7% | -44.2% | -68.3% | -1.4% | 17.4% |
| Forward P/E | 3.6x | — | — | — | 22.5x |
| Total Debt | $6M | $46M | $24M | $34M | $395K |
| Cash & Equiv. | $93M | $847K | $87M | $28M | $29M |
NAMI vs AIXI vs BBAI vs CLPS vs CODA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 24 | May 26 | Return |
|---|---|---|---|
| Jinxin Technology H… (NAMI) | 100 | 9.5 | -90.5% |
| Xiao-I Corporation (AIXI) | 100 | 12.5 | -87.5% |
| BigBear.ai Holdings… (BBAI) | 100 | 93.7 | -6.3% |
| CLPS Incorporation (CLPS) | 100 | 77.4 | -22.6% |
| Coda Octopus Group,… (CODA) | 100 | 152.0 | +52.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NAMI vs AIXI vs BBAI vs CLPS vs CODA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NAMI is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.73, Low D/E 3.4%, current ratio 2.17x
- Beta 0.73, current ratio 2.17x
- Lower P/E (3.6x vs 22.5x)
- 9.7% ROA vs AIXI's -65.3%
AIXI is the clearest fit if your priority is growth exposure.
- Rev growth 18.8%, EPS growth 52.7%, 3Y rev CAGR 29.3%
Among these 5 stocks, BBAI doesn't own a clear edge in any measured category.
CLPS ranks third and is worth considering specifically for income & stability.
- Dividend streak 3 yrs, beta 0.27, yield 14.6%
- Beta 0.27 vs BBAI's 3.31
- 14.6% yield; 3-year raise streak; the other 4 pay no meaningful dividend
CODA carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 8.4% 10Y total return vs BBAI's -57.6%
- 30.7% revenue growth vs BBAI's -19.3%
- 14.8% margin vs BBAI's -226.7%
- +78.9% vs NAMI's -86.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.7% revenue growth vs BBAI's -19.3% | |
| Value | Lower P/E (3.6x vs 22.5x) | |
| Quality / Margins | 14.8% margin vs BBAI's -226.7% | |
| Stability / Safety | Beta 0.27 vs BBAI's 3.31 | |
| Dividends | 14.6% yield; 3-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +78.9% vs NAMI's -86.9% | |
| Efficiency (ROA) | 9.7% ROA vs AIXI's -65.3% |
NAMI vs AIXI vs BBAI vs CLPS vs CODA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NAMI vs AIXI vs BBAI vs CLPS vs CODA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CODA leads in 2 of 6 categories
CLPS leads 1 • NAMI leads 0 • AIXI leads 0 • BBAI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CODA leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NAMI is the larger business by revenue, generating $406M annually — 14.5x CODA's $28M. CODA is the more profitable business, keeping 14.8% of every revenue dollar as net income compared to BBAI's -2.3%. On growth, CODA holds the edge at +28.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $406M | $115M | $127M | $299M | $28M |
| EBITDAEarnings before interest/tax | — | -$49M | -$75M | -$1M | $6M |
| Net IncomeAfter-tax profit | — | -$53M | -$289M | -$4M | $4M |
| Free Cash FlowCash after capex | — | -$2M | -$56M | $0 | $7M |
| Gross MarginGross profit ÷ Revenue | +28.8% | +64.3% | +25.8% | +22.8% | +66.3% |
| Operating MarginEBIT ÷ Revenue | +6.7% | -44.2% | -68.3% | -1.4% | +17.4% |
| Net MarginNet income ÷ Revenue | +5.0% | -45.9% | -2.3% | -1.3% | +14.8% |
| FCF MarginFCF ÷ Revenue | -8.8% | -2.0% | -44.3% | -2.3% | +24.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.7% | -64.9% | -0.9% | +15.3% | +28.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -114.7% | -29.9% | +52.0% | +75.8% | +3.0% |
Valuation Metrics
Evenly matched — NAMI and AIXI and BBAI and CLPS each lead in 1 of 4 comparable metrics.
Valuation Metrics
At 3.6x trailing earnings, NAMI trades at a 89% valuation discount to CODA's 32.2x P/E.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $8M | $19.7B | $25M | $134M |
| Enterprise ValueMkt cap + debt − cash | -$2M | $53M | $19.7B | $31M | $106M |
| Trailing P/EPrice ÷ TTM EPS | 3.60x | -0.45x | -5.09x | -3.48x | 32.16x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | 22.45x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 7.51x |
| EV / EBITDAEnterprise value multiple | -0.21x | — | — | — | 17.85x |
| Price / SalesMarket cap ÷ Revenue | 0.19x | 0.11x | 154.51x | 0.15x | 5.05x |
| Price / BookPrice ÷ Book value/share | 0.46x | — | 24.45x | 0.43x | 2.30x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | 22.20x |
Profitability & Efficiency
Evenly matched — NAMI and CODA each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
NAMI delivers a 94.8% return on equity — every $100 of shareholder capital generates $95 in annual profit, vs $-51 for BBAI. CODA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLPS's 0.59x. On the Piotroski fundamental quality scale (0–9), CODA scores 7/9 vs CLPS's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +94.8% | — | -50.7% | -6.1% | +7.2% |
| ROA (TTM)Return on assets | +9.7% | -65.3% | -35.3% | -3.2% | +6.6% |
| ROICReturn on invested capital | — | -34.4% | -19.5% | -7.9% | +11.2% |
| ROCEReturn on capital employed | +18.4% | -3.4% | -19.6% | -9.8% | +8.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 4 | 2 | 7 |
| Debt / EquityFinancial leverage | 0.03x | — | 0.04x | 0.59x | 0.01x |
| Net DebtTotal debt minus cash | -$87M | $45M | -$63M | $6M | -$28M |
| Cash & Equiv.Liquid assets | $93M | $846,593 | $87M | $28M | $29M |
| Total DebtShort + long-term debt | $6M | $46M | $24M | $34M | $394,932 |
| Interest CoverageEBIT ÷ Interest expense | — | -14.13x | -18.17x | — | — |
Total Returns (Dividends Reinvested)
CODA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CODA five years ago would be worth $14,969 today (with dividends reinvested), compared to $138 for AIXI. Over the past 12 months, CODA leads with a +78.9% total return vs NAMI's -86.9%. The 3-year compound annual growth rate (CAGR) favors BBAI at 14.3% vs AIXI's -75.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -49.2% | +68.1% | -28.6% | -10.3% | +25.1% |
| 1-Year ReturnPast 12 months | -86.9% | -79.2% | +36.7% | -5.4% | +78.9% |
| 3-Year ReturnCumulative with dividends | -91.3% | -98.6% | +49.5% | +0.5% | +34.5% |
| 5-Year ReturnCumulative with dividends | -91.3% | -98.6% | -56.9% | -69.3% | +49.7% |
| 10-Year ReturnCumulative with dividends | -91.3% | -98.6% | -57.6% | -78.5% | +844.4% |
| CAGR (3Y)Annualised 3-year return | -55.7% | -75.9% | +14.3% | +0.2% | +10.4% |
Risk & Volatility
Evenly matched — CLPS and CODA each lead in 1 of 2 comparable metrics.
Risk & Volatility
CLPS is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than BBAI's 3.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CODA currently trades 68.9% from its 52-week high vs NAMI's 9.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.73x | 0.94x | 3.31x | 0.27x | 1.00x |
| 52-Week HighHighest price in past year | $3.98 | $4.02 | $9.39 | $1.88 | $17.28 |
| 52-Week LowLowest price in past year | $0.37 | $0.08 | $2.96 | $0.80 | $5.98 |
| % of 52W HighCurrent price vs 52-week peak | +9.7% | +18.0% | +44.4% | +48.2% | +68.9% |
| RSI (14)Momentum oscillator 0–100 | 36.1 | 49.3 | 63.3 | 49.8 | 48.6 |
| Avg Volume (50D)Average daily shares traded | 67K | 60.6M | 34.6M | 15K | 256K |
Analyst Outlook
CLPS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: BBAI as "Hold", CODA as "Buy". Consensus price targets imply 43.9% upside for BBAI (target: $6) vs 17.6% for CODA (target: $14). CLPS is the only dividend payer here at 14.60% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | — | Buy |
| Price TargetConsensus 12-month target | — | — | $6.00 | — | $14.00 |
| # AnalystsCovering analysts | — | — | 4 | — | 1 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +14.6% | — |
| Dividend StreakConsecutive years of raises | — | — | 2 | 3 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $0.13 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
CODA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). CLPS leads in 1 (Analyst Outlook). 3 tied.
NAMI vs AIXI vs BBAI vs CLPS vs CODA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NAMI or AIXI or BBAI or CLPS or CODA a better buy right now?
For growth investors, Coda Octopus Group, Inc.
(CODA) is the stronger pick with 30. 7% revenue growth year-over-year, versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). Jinxin Technology Holding Company American Depositary Shares (NAMI) offers the better valuation at 3. 6x trailing P/E, making it the more compelling value choice. Analysts rate Coda Octopus Group, Inc. (CODA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NAMI or AIXI or BBAI or CLPS or CODA?
On trailing P/E, Jinxin Technology Holding Company American Depositary Shares (NAMI) is the cheapest at 3.
6x versus Coda Octopus Group, Inc. at 32. 2x.
03Which is the better long-term investment — NAMI or AIXI or BBAI or CLPS or CODA?
Over the past 5 years, Coda Octopus Group, Inc.
(CODA) delivered a total return of +49. 7%, compared to -98. 6% for Xiao-I Corporation (AIXI). Over 10 years, the gap is even starker: CODA returned +844. 4% versus AIXI's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NAMI or AIXI or BBAI or CLPS or CODA?
By beta (market sensitivity over 5 years), CLPS Incorporation (CLPS) is the lower-risk stock at 0.
27β versus BigBear. ai Holdings, Inc. 's 3. 31β — meaning BBAI is approximately 1120% more volatile than CLPS relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 59% for CLPS Incorporation — giving it more financial flexibility in a downturn.
05Which is growing faster — NAMI or AIXI or BBAI or CLPS or CODA?
By revenue growth (latest reported year), Coda Octopus Group, Inc.
(CODA) is pulling ahead at 30. 7% versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). On earnings-per-share growth, the picture is similar: Xiao-I Corporation grew EPS 52. 7% year-over-year, compared to -181. 4% for CLPS Incorporation. Over a 3-year CAGR, AIXI leads at 29. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NAMI or AIXI or BBAI or CLPS or CODA?
Coda Octopus Group, Inc.
(CODA) is the more profitable company, earning 15. 5% net margin versus -230. 2% for BigBear. ai Holdings, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CODA leads at 17. 1% versus -65. 3% for BBAI. At the gross margin level — before operating expenses — AIXI leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NAMI or AIXI or BBAI or CLPS or CODA more undervalued right now?
Analyst consensus price targets imply the most upside for BBAI: 43.
9% to $6. 00.
08Which pays a better dividend — NAMI or AIXI or BBAI or CLPS or CODA?
In this comparison, CLPS (14.
6% yield) pays a dividend. NAMI, AIXI, BBAI, CODA do not pay a meaningful dividend and should not be held primarily for income.
09Is NAMI or AIXI or BBAI or CLPS or CODA better for a retirement portfolio?
For long-horizon retirement investors, CLPS Incorporation (CLPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
27), 14. 6% yield). BigBear. ai Holdings, Inc. (BBAI) carries a higher beta of 3. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLPS: -78. 5%, BBAI: -57. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NAMI and AIXI and BBAI and CLPS and CODA?
These companies operate in different sectors (NAMI (Communication Services) and AIXI (Technology) and BBAI (Technology) and CLPS (Technology) and CODA (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NAMI is a small-cap deep-value stock; AIXI is a small-cap high-growth stock; BBAI is a mid-cap quality compounder stock; CLPS is a small-cap high-growth stock; CODA is a small-cap high-growth stock. CLPS pays a dividend while NAMI, AIXI, BBAI, CODA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.